Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-β-L-cytidine (β- L-d4C) and 2',3'-dideoxy-2'-3'-didehydro-β-L-5-fluorocytidine (β-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human immunodeficiency virus (HIV) in vitro

Journal of Medicinal Chemistry

Volumn 39, Issue 9, 1996, Pages 1757-1759

  Lin, T S ^a   Luo, M Z ^a   Liu, M C ^a   Zhu, Y L ^a   Gullen, E ^a   Dutschman, G E ^a   Cheng , Y C ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEHYDRO 2',3' DIDEOXYCYTIDINE; ANTIVIRUS AGENT; ELVUCITABINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; NONHUMAN; VIRUS INHIBITION;

ANTIVIRAL AGENTS; DRUG DESIGN; HEPATITIS B VIRUS; HIV; HUMANS; ZALCITABINE;

EID: 0029881506     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950836q     Document Type: Article

References (0)